| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0004600 | Intron-Exon-Intron | chr10:31642732-31647262 | chr10:31353803-31358333 | 151 nt | 0.3841 |
| hsa_ZEB1_0004700 | Intron-Exon-Intron | chr10:31642732-31676195 | chr10:31353803-31387266 | 297 nt | 0.4141 |
| hsa_ZEB1_0004800 | Intron-Exon-Intron | chr10:31642732-31678624 | chr10:31353803-31389695 | 193 nt | 0.3886 |
| hsa_ZEB1_0004900 | Intron-Exon-Intron | chr10:31642745-31644121 | chr10:31353816-31355192 | 89 nt | 0.3820 |
| hsa_ZEB1_0005000 | Intron-Exon-Intron | chr10:31642745-31647262 | chr10:31353816-31358333 | 238 nt | 0.4412 |
| hsa_ZEB1_0005100 | Intron-Exon-Intron | chr10:31642745-31676727 | chr10:31353816-31387798 | 79 nt | 0.3671 |
| hsa_ZEB1_0005200 | Intron-Exon-Intron | chr10:31644037-31750166 | chr10:31355108-31461237 | 720 nt | 0.4014 |
| hsa_ZEB1_0005600 | Intron-Exon-Intron | chr10:31644073-31655054 | chr10:31355144-31366125 | 202 nt | 0.4307 |
| hsa_ZEB1_0005700 | Intron-Exon-Intron | chr10:31644073-31662102 | chr10:31355144-31373173 | 394 nt | 0.4162 |
| hsa_ZEB1_0005800 | Intron-Exon-Intron | chr10:31644073-31663893 | chr10:31355144-31374964 | 367 nt | 0.3678 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].